Pediatric Respiratory Syncytial Virus Diagnostic Testing Performance: A Systematic Review and Meta-analysis
Chukwuemeka Onwuchekwa, Elizabeth Begier(Pfizer (United States)), Daniel Curcio(Pfizer (Ireland)), Mariana Siapka, Jessica E. Atwell(Pfizer (Ireland)), Zuleika Aponte‐Torres(National Center for Emerging and Zoonotic Infectious Diseases), Belen Machado, Warren V. Kalina(Pfizer (United States)), Neha Agarwal, Mark H. Rozenbaum(Pfizer (Netherlands)), Harish Nair(Public Health Foundation of India), Michelle Rubbrecht, Hilde Vroling(Unknown), Sonia Menon(International Union Against Tuberculosis and Lung Disease), Bradford D Gessner(Pfizer (United States)), Laura Mora Moreo
Cited by 46
Related Papers
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
Global burden of childhood pneumonia and diarrhoea
|The Lancet|2013|2.4k
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
|Nature|2020|1.6k